Skip to main content
CERUS CORP logo

CERUS CORP — Investor Relations & Filings

Ticker · CERS ISIN · US1570851014 LEI · 254900BIEY9XIDA04Q21 US Manufacturing
Open in API
Filings indexed 1,012 across all filing types
Latest filing 2026-06-08 Capital/Financing Update
Country US United States of America
Listing US CERS

About CERUS CORP

https://www.cerus.com/

Cerus Corporation is a biomedical products company dedicated to safeguarding the world's blood supply. The company develops and commercializes the INTERCEPT Blood System, a pathogen inactivation technology designed to reduce the risk of transfusion-transmitted infections. The system inactivates a broad spectrum of viruses, bacteria, parasites, and leukocytes in donated blood components. It is used for platelets and plasma, with a system for red blood cells in development. Cerus provides its technology to blood centers and hospitals, aiming to establish a new standard of care for blood safety.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 90% confidence The document is a U.S. SEC Form 8-K “Current Report” describing Cerus Corporation’s entry into and termination of amended and restated credit agreements (term loan and revolving credit facility), detailing borrowing amounts, interest rates, covenant requirements and use of proceeds. This is clearly an update on the company’s financing arrangements. It is not an earnings release, management change or proxy, but a financing transaction announcement. Therefore, it fits the “Capital/Financing Update” category (CAP).
2026-06-08 English
8-K
Regulatory Filings
2026-06-03 English
SD
Regulatory Filings Classification · 85% confidence The document is an SEC Form SD (“Specialized Disclosure Report”) filed under Rule 13p-1 for conflict minerals disclosure. It is not an earnings release, proxy, AGM material, or financial statement report (10-K, 10-Q/IR). There is no bespoke category for Form SD in our taxonomy, so this falls under general regulatory filings. Therefore it should be classified as RNS (Regulatory Filings).
2026-05-29 English
10-Q - CERUS CORP (0001020214) (Filer)
Interim / Quarterly Report Q1 2026
2026-04-30 English
ARS - CERUS CORP (0001020214) (Filer)
Annual Report
2026-04-22 English
DEF 14A - CERUS CORP (0001020214) (Filer)
Proxy Solicitation & Information Statement
2026-04-22 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.